John P. McLaughlin

2010

In 2010, John P. McLaughlin earned a total compensation of $1.7M as President and Chief Executive Officer at PDL BioPharma, a 59% increase compared to previous year.

Compensation breakdown

Bonus$742,500
Non-Equity Incentive Plan$257,500
Salary$515,000
Other$186,013
Total$1,701,013

McLaughlin received $742.5K in bonus, accounting for 44% of the total pay in 2010.

McLaughlin also received $257.5K in non-equity incentive plan, $515K in salary and $186K in other compensation.

Rankings

In 2010, John P. McLaughlin's compensation ranked 3,549th out of 10,439 executives tracked by ExecPay. In other words, McLaughlin earned more than 66.0% of executives.

ClassificationRankingPercentile
All
3,549
out of 10,439
66th
Division
Manufacturing
1,235
out of 3,838
68th
Major group
Chemicals And Allied Products
241
out of 921
74th
Industry group
Drugs
134
out of 680
80th
Industry
Biological Products, Except Diagnostic Substances
26
out of 142
82nd
Source: SEC filing on April 10, 2013.

McLaughlin's colleagues

We found three more compensation records of executives who worked with John P. McLaughlin at PDL BioPharma in 2010.

2010

Christine Larson

PDL BioPharma

Chief Financial Officer

2010

Christopher Stone

PDL BioPharma

General Counsel

2010

Karen Wilson

PDL BioPharma

Former Vice President of Finance and Principal Accounting Officer

News

You may also like